Review of the current status of drug-resistant tuberculosis in Saudi Arabia

Annals of Saudi Medicine

Volumn 22, Issue 3-4, 2002, Pages 236-238

  Abu Amero, Khaled K ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDLINE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SAUDI ARABIA; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 0036588174     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2002.236     Document Type: Article

References (23)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
2. Willcox PA. Drug-resistant tuberculosis: worldwide trends, problems specific to Eastern Europe and other hotspots, and the threat to developing countries. Curr Opin Pulm Med 2001;7:148-53.
3. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ. Reniero A, et al. Global trends in resistance to antituberculosis drugs. World Health Organization/International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001;344:1294-303.
4. Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: review of the world situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997;24:121-30.
5. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. WHO/IUATLD Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998;338: 1641-49.
6. Schwoebel V, Lambregts van Weezenbeek CS. Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, et al. Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a WHO/IUATLD Working Group. Eur Respir J 2000;16:364-71.
7. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug-resistant pulmonary tuberculosis in the Eastern province of Saudi Arabia. Saudi Med J 2001;22:776-9.
8. Al-Orainey IO. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle 1989;70:207-10.
9. Shanks NJ, Khalifa I, Al-Kalai D. Tuberculosis in Saudi Arabia. Saudi Med J 1983;4:151-6.
10. Schiott C, Engbaek H, Vergmann B, Al-Motez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in Gizan area, Saudi Arabia. Saudi Med J 1985;6:375-8.
11. Jarallah JS, Elias AK, Al-Hajjaj MS, Bukhari MS, Al-Shareef HM, Al-Shammari SA. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tuber Lung Dis 1992;73:113-5.
12. Al-Orainey IO. Resistance to standard antituberculous drugs in Saudi Arabia. Saudi Med J 1989;7:363-8.
13. Al-Rasheed AM, Abu-Amero KK, Abdulsamad W, Alattayah S. Low prevalence of multi-drug resistance tuberculosis in Saudi patients: an eleven-year retrospective study (abstract). 20th Annual Congress of the European Society of Mycobacteriology, Lucerne, Switzerland (1999).
14. Ellis ME, Al-Hajjar S, Bokhari H, Qadri SH. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis 1996;28:591-5.
15. Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among indigenous and non-indigenous populations. Tuberculosis 1991;72:51-5.
16. Kinsara A, Gilpin C, Osoba A. Review of tuberculosis at the King Khalid National Guard Hospital, Jeddah, Saudi Arabia. Saudi Med J 1997;19:212-4.
17. Khan MY, Kinsara AG, Osoba AO, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents Chemother 2001;17:415-8.
18. Anonymous. WHO Report 2001. Global Tuberculosis Control. Communicable Diseases Publication, World Health Organization, Geneva (Switzerland), 2001.
19. Milaat WA, Ali A, Afif H, Ghabrah T. Epidemology of tuberculosis in Jeddah region, Saudi Arabia. Saudi Med J 1994;15:133-7.
20. Al-Zaeer A, Mashlah A, Fakim N, Al-Sugair N, Al-Hedaithy M, AlMajed S, et al. Tuberculosis is the commonest cause of pneumonia requiring hospitilaization during Hajj (pilgrimage to Makkah). J Infect Dis 1998;36:303-6.
21. Al-Kassimi FA, Abdullah AK, Al-Hajjaji MS, Al-Orainey IO, Bamgboye EA, Chowdhury MN. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tuber Lung Dis 1993;74: 254-60.
22. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Intern J Tuber Lung Dis 2000;4:34-49.
23. Al-Kassimi FA. Review of tuberculosis in Saudi Arabia. Saudi Med J 1994;15:192-5.